tradingkey.logo

Metagenomi Inc

MGX
1.540USD
+0.130+9.22%
終値 02/06, 16:00ET15分遅れの株価
57.82M時価総額
損失額直近12ヶ月PER

Metagenomi Inc

1.540
+0.130+9.22%

詳細情報 Metagenomi Inc 企業名

Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed a modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. The Company uses artificial intelligence and its metagenomics platform to develop curative genetic medicines.

Metagenomi Incの企業情報

企業コードMGX
会社名Metagenomi Inc
上場日Feb 09, 2024
最高経営責任者「CEO」Irish (Jian)
従業員数202
証券種類Ordinary Share
決算期末Feb 09
本社所在地5959 Horton St
都市EMERYVILLE
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号94608
電話番号15108714880
ウェブサイトhttps://metagenomi.co/
企業コードMGX
上場日Feb 09, 2024
最高経営責任者「CEO」Irish (Jian)

Metagenomi Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.36M
-3830.00%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
824.33K
+246898.00%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-5239.00%
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
--
--
,
,
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
--
--
Mr. Laurence E. Reid, Ph.D.
Mr. Laurence E. Reid, Ph.D.
Director
Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.36M
-3830.00%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
824.33K
+246898.00%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-5239.00%
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--

収益内訳

会社から関連データがまだ開示されていません。
会社から関連データがまだ開示されていません。
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Sun, Feb 1
更新時刻: Sun, Feb 1
株主統計
種類
株主統計
株主統計
比率
Bayer HealthCare LLC
10.79%
Thomas (Brian C)
6.29%
Humboldt Capital, LLC
5.05%
The Vanguard Group, Inc.
3.38%
Bernales (Sebastian Ph.D.)
3.12%
他の
71.36%
株主統計
株主統計
比率
Bayer HealthCare LLC
10.79%
Thomas (Brian C)
6.29%
Humboldt Capital, LLC
5.05%
The Vanguard Group, Inc.
3.38%
Bernales (Sebastian Ph.D.)
3.12%
他の
71.36%
種類
株主統計
比率
Corporation
15.85%
Individual Investor
12.68%
Investment Advisor
7.31%
Hedge Fund
3.18%
Venture Capital
3.00%
Investment Advisor/Hedge Fund
1.77%
Research Firm
1.39%
Sovereign Wealth Fund
0.67%
他の
54.14%

機関投資家保有株

更新時刻: Thu, Jan 1
更新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
166
6.70M
17.86%
-8.85M
2025Q3
156
7.24M
19.30%
-9.50M
2025Q2
159
20.26M
54.19%
-7.71M
2025Q1
157
20.44M
54.67%
-7.64M
2024Q4
143
21.51M
57.48%
-2.78M
2024Q3
116
23.74M
63.40%
-1.13M
2024Q2
94
26.05M
69.54%
+4.67M
2024Q1
65
26.68M
71.20%
+16.22M

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Bayer HealthCare LLC
4.05M
10.79%
--
--
Sep 30, 2024
Thomas (Brian C)
2.36M
6.29%
-3.83K
-0.16%
Dec 05, 2025
Humboldt Capital, LLC
1.90M
5.05%
--
--
Apr 14, 2025
The Vanguard Group, Inc.
1.24M
3.31%
-16.13K
-1.28%
Sep 30, 2025
Bernales (Sebastian Ph.D.)
1.17M
3.12%
--
--
Apr 14, 2025
Irish (Jian)
824.33K
2.2%
+246.90K
+42.76%
Dec 05, 2025
Sozo Ventures LLC
581.58K
1.55%
--
--
Sep 30, 2025
Catalio Capital Management, LP
528.99K
1.41%
--
--
Sep 30, 2025
Peapod Lane Capital LLC
513.82K
1.37%
+5.71K
+1.12%
Sep 30, 2025
Millennium Management LLC
310.69K
0.83%
-72.34K
-18.89%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Tue, Dec 2
更新時刻: Tue, Dec 2
銘柄名
比率
iShares Micro-Cap ETF
0.01%
Avantis US Small Cap Equity ETF
0%
iShares Russell 2000 Value ETF
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
Schwab U.S. Small-Cap ETF
0%
iShares Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 Growth ETF
0%
iShares Micro-Cap ETF
比率0.01%
Avantis US Small Cap Equity ETF
比率0%
iShares Russell 2000 Value ETF
比率0%
Proshares Ultra Russell 2000
比率0%
ProShares Hedge Replication ETF
比率0%
Global X Russell 2000 ETF
比率0%
Schwab U.S. Small-Cap ETF
比率0%
iShares Russell 2000 ETF
比率0%
ProShares UltraPro Russell2000
比率0%
iShares Russell 2000 Growth ETF
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
KeyAI